$239 Million is the total value of Pivotal bioVenture Partners Investment Advisor LLC's 10 reported holdings in Q4 2021. The portfolio turnover from Q3 2021 to Q4 2021 was 11.1% .
| Value | Shares | ↓ Weighting | ||||||
|---|---|---|---|---|---|---|---|---|
| KRTX | KARUNA THERAPEUTICS INC | $111,705,000 | +7.1% | 852,708 | 0.0% | 46.71% | +26.7% | |
| PCVX | Sell | VAXCYTE INC | $26,442,000 | -25.8% | 1,111,485 | -20.9% | 11.06% | -12.3% |
| RALLYBIO CORP | $21,668,000 | -45.7% | 2,271,311 | 0.0% | 9.06% | -35.8% | ||
| New | EXSCIENTIA PLCads | $15,260,000 | – | 772,285 | +100.0% | 6.38% | – | |
| AKUS | AKOUOS INC | $15,250,000 | -26.8% | 1,794,088 | 0.0% | 6.38% | -13.4% | |
| ARQT | ARCUTIS BIOTHERAPEUTICS INC | $11,802,000 | -13.2% | 569,041 | 0.0% | 4.94% | +2.7% | |
| INZY | INOZYME PHARMA INC | $10,852,000 | -41.2% | 1,591,154 | 0.0% | 4.54% | -30.4% | |
| ALGS | ALIGOS THERAPEUTICS INC | $10,405,000 | -23.5% | 876,548 | 0.0% | 4.35% | -9.4% | |
| BOLT | BOLT BIOTHERAPEUTICS INC | $9,268,000 | -61.3% | 1,891,467 | 0.0% | 3.88% | -54.2% | |
| FUSN | Sell | FUSION PHARMACEUTICALS INC | $6,509,000 | -48.6% | 1,598,377 | -0.0% | 2.72% | -39.2% |
Other managers
Other managers that, in addition to the filing manager(s), that filed the EDGAR filing(s):
Original filings
The following EDGAR filing(s) were analyzed to create this report:
- View 13F-HR filed 2022-02-14
Top long-term holdings
| Name | Quarters owned | Latest quarter owned | Max weighting |
|---|---|---|---|
| KARUNA THERAPEUTICS INC | 12 | Q3 2023 | 65.4% |
| VAXCYTE INC | 12 | Q3 2023 | 19.5% |
| INOZYME PHARMA INC | 12 | Q3 2023 | 10.8% |
| ARCUTIS BIOTHERAPEUTICS INC | 12 | Q3 2023 | 6.2% |
| FUSION PHARMACEUTICALS INC | 12 | Q3 2023 | 6.2% |
| ALIGOS THERAPEUTICS INC | 12 | Q3 2023 | 8.0% |
| BOLT BIOTHERAPEUTICS INC | 11 | Q3 2023 | 20.0% |
| RALLYBIO CORP | 9 | Q3 2023 | 14.1% |
| AKOUOS INC | 8 | Q3 2022 | 11.7% |
| EXSCIENTIA PLC | 8 | Q3 2023 | 6.4% |
View Pivotal bioVenture Partners Investment Advisor LLC's complete holdings history.
Latest filings
| Type | Filed |
|---|---|
| 13F-HR | 2024-02-13 |
| 13F-HR | 2023-11-13 |
| 13F-HR | 2023-08-11 |
| 13F-HR | 2023-05-12 |
| 13F-HR | 2023-02-13 |
| 13F-HR | 2022-11-10 |
| 13F-HR | 2022-08-12 |
| 13F-HR | 2022-05-13 |
| 13F-HR | 2022-02-14 |
| 13F-HR | 2021-11-15 |
View Pivotal bioVenture Partners Investment Advisor LLC's complete filings history.
All filings
- Holdings (13F-HR)
- Significant ownership (13-D/G)
- Insider transactions (4, 5, 6)
- Events (8-K)
- Shareholder votes (proxy)
View complete filings history.